NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,259,967 | -9.0% | 51,067 | +0.0% | 0.00% | -50.0% |
Q2 2023 | $2,483,694 | -12.5% | 51,047 | -0.1% | 0.00% | 0.0% |
Q1 2023 | $2,837,016 | +227.9% | 51,099 | +137.3% | 0.00% | +100.0% |
Q4 2022 | $865,125 | +15.2% | 21,534 | -37.2% | 0.00% | 0.0% |
Q3 2022 | $750,750 | +23.7% | 34,270 | +99.9% | 0.00% | – |
Q2 2022 | $607,000 | -97.5% | 17,140 | -97.2% | 0.00% | -100.0% |
Q1 2022 | $24,708,000 | -77.6% | 607,329 | -48.7% | 0.01% | -73.9% |
Q4 2021 | $110,459,000 | -11.2% | 1,182,764 | +5.9% | 0.05% | -14.8% |
Q3 2021 | $124,410,000 | +56.9% | 1,116,386 | +59.8% | 0.05% | +58.8% |
Q2 2021 | $79,311,000 | +11.7% | 698,593 | -0.1% | 0.03% | +6.2% |
Q1 2021 | $70,973,000 | -8.1% | 698,962 | -9.9% | 0.03% | -11.1% |
Q4 2020 | $77,217,000 | +22.8% | 775,894 | -10.9% | 0.04% | +9.1% |
Q3 2020 | $62,885,000 | – | 870,497 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |